Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

Clinical trial NCT02635035 · COMPLETED

Trial details

NCT number: NCT02635035
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder Attention Deficit Hyperactivity Disorder

Start date: 2015-11-01
Primary completion: 2019-01-09
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.